new_0222_0549|FULC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0549|FULC|1|Fulcrum Therapeutics Inc Total Current Assets (Quarterly) (USD)|Fulcrum Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Fulcrum Therapeutics Inc Inventories (Quarterly) (USD)|Fulcrum Therapeutics Inc Net PP&E (Quarterly) (USD)|Fulcrum Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Fulcrum Therapeutics Inc Total Liabilities (Quarterly) (USD)|Fulcrum Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Fulcrum Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Fulcrum Therapeutics Inc Total Deposits (Quarterly) (USD)|Fulcrum Therapeutics Inc Book Value (Quarterly) (USD)|Fulcrum Therapeutics Inc Retained Earnings (Quarterly) (USD)|Fulcrum Therapeutics Inc Treasury Stock (Quarterly) (USD)|Fulcrum Therapeutics Inc EV to Revenues|Fulcrum Therapeutics Inc EV to Earnings|Fulcrum Therapeutics Inc EV to Free Cash Flow|Fulcrum Therapeutics Inc EV to Assets (Quarterly)|Fulcrum Therapeutics Inc PS Ratio|Fulcrum Therapeutics Inc PE Ratio|Fulcrum Therapeutics Inc Price to Book Value|Fulcrum Therapeutics Inc PEG Ratio|Fulcrum Therapeutics Inc Debt to Equity Ratio|Fulcrum Therapeutics Inc Dividend Yield|Fulcrum Therapeutics Inc Shareholder Yield (TTM)|Fulcrum Therapeutics Inc Percent of Shares Outstanding Short|Fulcrum Therapeutics Inc Total Receivables (Quarterly) (USD)|Fulcrum Therapeutics Inc Total Payables (Quarterly) (USD)|Fulcrum Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Fulcrum Therapeutics Inc Return on Invested Capital|Fulcrum Therapeutics Inc Quality Ratio Score|Fulcrum Therapeutics Inc Momentum Score|Fulcrum Therapeutics Inc Beta (1Y)|Fulcrum Therapeutics Inc Sustainable Growth Rate (TTM)|Fulcrum Therapeutics Inc Institutional Investor Ownership Percentage|Fulcrum Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Fulcrum Therapeutics Inc Total Employees (Annual)|Fulcrum Therapeutics Inc EPS Diluted (Quarterly) (USD)|Fulcrum Therapeutics Inc Shares Outstanding|Fulcrum Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Fulcrum Therapeutics Inc Ordinary Shares Number (Quarterly)|Fulcrum Therapeutics Inc Payout Ratio|Fulcrum Therapeutics Inc Quick Ratio (Quarterly)|Fulcrum Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Fulcrum Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Fulcrum Therapeutics Inc Effective Tax Rate (TTM)|Fulcrum Therapeutics Inc Return on Equity|Fulcrum Therapeutics Inc Net Income (TTM) (USD)|Fulcrum Therapeutics Inc Revenue (TTM) (USD)|Fulcrum Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Fulcrum Therapeutics Inc Revenue (Quarterly) (USD)|Fulcrum Therapeutics Inc Gross Profit (Quarterly) (USD)|Fulcrum Therapeutics Inc SG&A Expense (Quarterly) (USD)|Fulcrum Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Fulcrum Therapeutics Inc Net Income (Quarterly) (USD)|Fulcrum Therapeutics Inc Net Interest Income (Quarterly) (USD)|Fulcrum Therapeutics Inc Price (USD)|Fulcrum Therapeutics Inc Total Return Price (USD)|Fulcrum Therapeutics Inc Enterprise Value (USD)|Fulcrum Therapeutics Inc 30-Day Average Daily Volume|Fulcrum Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0549|FULC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0549|FULC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0549|FULC|5|91.3333333333|91.3333333333||91.3333333333||91.3333333333|91.3333333333|91.3333333333||91.3333333333|91.3333333333|91.3333333333|1.44918032787|91.25|6.95714285714|91.4285714286|1.44918032787||1.44694533762||91.4285714286|1.44725111441|91.25|15.2096774194|91.3333333333|91.3333333333|91.3333333333|91.25||32.1176470588|30.3684210526|91.25||91.4|305|91.4|31.0322580645|91.5|91.3333333333|91.25|91.4285714286|91.4|91.4||91.25|91.3333333333|91.25||91.4285714286||91.4|91.4|91.4|91.6666666667|6.95714285714|6.95714285714|6.95714285714|6.96268656716|1.44285714286||
new_0222_0549|FULC|6|12|12||12||12|12|12||12|12|12|305|4|140|7|305||622||7|673|4|62|12|12|12|4||17|19|4||15|3|15|31|6|12|4|7|15|15||4|12|4||7||15|15|15|3|140|140|140|134|420||
new_0222_0549|FULC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0549|FULC|201803||||||||||||||||||||||||||||||||||16.94||-0.4586||||||-0.4586|-0.017||||||||1.737|-6.94|-6.94||||||||
new_0222_0549|FULC|201806||||||||||||||||||||||||||||||||||16.94||-0.5251||||||-0.4632|||||||||2.061|-7.846|-7.846|-0.005|||||||
new_0222_0549|FULC|201809||||||||||||||||||||||||||||||||||16.94||-0.6376||||||-0.5279|0.017||||||||2.125|-8.943|-8.943|0.138|||||||
new_0222_0549|FULC|201812|74.095|72.797||10.546||9.771|4.229|5.542||-63.67|-68.124||||||||||||||0.501|1.263|139.672|||||||16.94||-0.6896|||23.34|||-0.523||||-32.588|||||2.391|-8.859|-8.859|0.385|||||||
new_0222_0549|FULC|201903|63.996|62.452||10.225||10.139|4.69|5.449||65.449|-104.967||||||||||||||0.489|2.522|0.018|||||||23.34||-1.7088||-0.034|23.34|||-1.5785||||-62.491|||||2.598|-36.843|-36.843||||||||
new_0222_0549|FULC|201906|51.366|49.628||10.005||11.696|6.343|5.353||-111.681|-118.136||||-11.3521|||||||||0.0661|0.096|3.081|165.138|||||||23.34|62|-0.7052|23.34||23.34|||-0.5642||||-67.814|||||2.634|-13.169|-13.169||13.25|13.25|424.763|114938.6||10.92|
new_0222_0549|FULC|201909|105.222|101.597||9.583||13.828|8.585|5.243||102.128|-134.678||||-7.884||||1.4666|||||0.8112|0.159|4.533|0.023|||||||17.785||-0.97|22.5579||22.5579|||-0.97|-64.443|||-75.413|||||3.51|-16.542|-16.542||7.69|7.69|294.9957|73550.1||6.06|15.01
new_0222_0549|FULC|201912|100.083|96.713||9.205||23.286|12.14|11.146||87.153|-150.801||||-6.7035||||4.3254|||||0.4393|0.111|2.186|0.023|||||||22.6544|73|-0.71|22.6544||22.6544|||-0.71|0.27|||-82.677|||||4.403|-16.123|-16.123||17.45|17.45|305.6947|61512.5667||17.4|16.17
new_0222_0549|FULC|202003|84.323|81.207||9.362||24.225|14.182|10.043||70.631|-169.253||||-4.16|2.013|||3.8531|||||2.0419|0.502|3.937|0.023|||||||22.719||-0.81|22.7931||22.7931||5.7615|-0.81||||-64.286|||0.75||5.064|-18.452|-18.452||11.94|11.94|190.9426|120732.5||12.05|19.29
new_0222_0549|FULC|202006|134.784|131.738||8.91||22.731|13.943|8.788||122.131|-184.938||||-7.639|2.5278|||4.077|||||2.7588|0.96|3.571|0.027|||8|2.0527|||23.854||-0.66|27.2238||27.2238||9.5172|-0.66|-64.368|||-66.802|||2||5.149|-15.685|-15.685||18.29|18.29|366.1853|105737.9333|14.5848|16.11|7.615
new_0222_0549|FULC|202009|132.112|127.025||8.395||37.23|26.455|10.775||104.985|-203.9||||-1.6215|0.6278|||2.0604|||||4.2032|0.663|3.634|0.027|||3|1.0027|||27.261||-0.7|27.278||27.278||4.8266|-0.7|0.158|||-69.222|||1.848||5.312|-18.962|-18.962||7.63|7.63|77.7269|232024.7|19.4277|10.48|10.68
new_0222_0549|FULC|202012|119.51|112.914||8.397||34.396|26.725|7.671||95.181|-221.62||24.2868|-3.0258|-5.2789|1.6537|33.6405||3.4376||||-21.3774|3.586|2.707|4.079|0.028|-72.0936||4|0.487|-73.7573||27.553|73|-0.64|27.9416||27.9416||4.3263|-0.64|-5.736||-73.7573|-70.819|8.823||4.225||5.867|-17.72|-17.72||12.18|12.18|207.4695|150356.6333|-29.6274|12.05|13.73
new_0222_0549|FULC|202103|146.987|143.856||7.834||28.722|22.631|6.091||127.754|-238.619||18.6679|-3.4614|-4.7372|1.5345|25.2274||3.0055||||-30.5681|2.3551|0.634|4.797|0.033|-66.6107||1|-0.7066|-66.6107||31.51||-0.54|32.5944||32.5944||6.3846|-0.54|-47.424||-66.6107|-69.366|12.862||4.789||5.498|-16.999|-16.999||11.43|11.43|260.5292|110510.2|-1.34|11.66|9.12
new_0222_0549|FULC|202106|128.511|125.55||7.745||26.989|22.51|4.479||110.89|-258.267||14.2179|-2.9555|-2.9961|1.5718|20.4471||3.0866||||-15.4803|2.6179|0.823|4.498|0.033|-65.3625||1|-1.5224|-65.3625||32.636||-0.6|32.6597||32.6597||5.6141|-0.6|0.017||-65.3625|-73.329|15.243||4.381||6.685|-19.648|-19.648||9.51|9.51|166.927|207148.0333|-42.7009|7.33|29.7
new_0222_0549|FULC|202109|246.187|240.345||7.749||24.938|20.597|4.341||230.609|-278.983||49.2577|-12.0253|-16.2791|3.5332|49.3656||4.9575||||-16.5031|5.0949|1.558|3.742|0.041|-56.0807||10|1.7793|-56.0807||36.606||-0.57|40.526||40.526||11.7446|-0.57|-135.527||-56.0807|-75.083|18.33||4.935||8.628|-20.716|-20.716||27.26|27.26|972.9844|1003152.0333|255.7377|24.36|14.33
new_0222_0549|FULC|202112|225.998|218.162||7.368||23.461|19.199|4.262||211.539|-302.467||26.1188|-6.1909|-6.0906|2.1299|32.6298||3.3974||||-25.4435|4.5178|4.11|4.788|0.041|-52.094||7|3.3109|-52.094||40.635|104|-0.58|40.6262||40.6262||11.5773|-0.58|0.077||-52.094|-80.847|19.163||5.058||9.705|-23.484|-23.484||17.66|17.66|475.7468|528312.9|51.0675|12.49|10.22
new_0222_0549|FULC|202203|||||||||||||27.5498||-6.5835||33.8656||3.527||||||||||||||||||||||||||||||||||||18.36|18.36|527.937|500760|58.5492||